Dyne Therapeutics Stock Price Prediction
| DYN Stock | USD 29.69 0.04 0.13% |
Oversold Vs Overbought
30
Oversold | Overbought |
EPS Estimate Next Quarter (0.74) | EPS Estimate Current Year (3.48) | EPS Estimate Next Year (3.46) | Wall Street Target Price 51.4 | EPS Estimate Current Quarter (0.71) |
Using Dyne Therapeutics hype-based prediction, you can estimate the value of Dyne Therapeutics from the perspective of Dyne Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Dyne Therapeutics Hype to Price Pattern
Investor biases related to Dyne Therapeutics' public news can be used to forecast risks associated with an investment in Dyne. The trend in average sentiment can be used to explain how an investor holding Dyne can time the market purely based on public headlines and social activities around Dyne Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Dyne Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Dyne Therapeutics.
The fear of missing out, i.e., FOMO, can cause potential investors in Dyne Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Dyne because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Dyne Therapeutics after-hype prediction price | USD 30.3 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Dyne |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dyne Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Dyne Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Dyne Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Dyne Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Dyne Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Dyne Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Dyne Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Dyne Therapeutics' historical news coverage. Dyne Therapeutics' after-hype downside and upside margins for the prediction period are 24.93 and 35.67, respectively. We have considered Dyne Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Dyne Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Dyne Therapeutics is based on 3 months time horizon.
Dyne Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Dyne Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dyne Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Dyne Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 5.37 | 0.61 | 0.16 | 11 Events / Month | 9 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
29.69 | 30.30 | 2.05 |
|
Dyne Therapeutics Hype Timeline
On the 24th of November Dyne Therapeutics is traded for 29.69. The entity has historical hype elasticity of 0.61, and average elasticity to hype of competition of 0.16. Dyne is anticipated to increase in value after the next headline, with the price projected to jump to 30.3 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 2.05%, whereas the daily expected return is currently at -0.47%. The volatility of related hype on Dyne Therapeutics is about 1572.8%, with the expected price after the next announcement by competition of 29.85. Dyne Therapeutics has 27.41 M in debt with debt to equity (D/E) ratio of 0.11, which may show that the company is not taking advantage of profits from borrowing. Considering the 90-day investment horizon the next anticipated press release will be in about 11 days. Check out Dyne Therapeutics Basic Forecasting Models to cross-verify your projections.Dyne Therapeutics Related Hype Analysis
Having access to credible news sources related to Dyne Therapeutics' direct competition is more important than ever and may enhance your ability to predict Dyne Therapeutics' future price movements. Getting to know how Dyne Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Dyne Therapeutics may potentially react to the hype associated with one of its peers.
Dyne Therapeutics Additional Predictive Modules
Most predictive techniques to examine Dyne price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dyne using various technical indicators. When you analyze Dyne charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Dyne Therapeutics Predictive Indicators
The successful prediction of Dyne Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Dyne Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Dyne Therapeutics based on analysis of Dyne Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Dyne Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Dyne Therapeutics's related companies. | 2023 | 2024 (projected) | Payables Turnover | 0.11 | 0.1 | Days Of Inventory On Hand | 49.86 | 48.73 |
Story Coverage note for Dyne Therapeutics
The number of cover stories for Dyne Therapeutics depends on current market conditions and Dyne Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Dyne Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Dyne Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Dyne Therapeutics Short Properties
Dyne Therapeutics' future price predictability will typically decrease when Dyne Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Dyne Therapeutics often depends not only on the future outlook of the potential Dyne Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dyne Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 59.7 M | |
| Cash And Short Term Investments | 123.1 M |
Check out Dyne Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne Therapeutics. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.58) | Return On Assets (0.40) | Return On Equity (0.69) |
The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.